BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32911349)

  • 1. Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Cuesta MJ; Sánchez-Torres AM; Lorente-Omeñaca R; Zandio M; Moreno-Izco L; Peralta V
    Psychiatry Res; 2020 Nov; 293():113404. PubMed ID: 32911349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients.
    Liu Y; Wang G; Jin H; Lyu H; Liu Y; Guo W; Shi C; Meyers J; Wang J; Zhao J; Wu R; Smith RC; Davis JM
    Psychiatry Res; 2019 Apr; 274():235-242. PubMed ID: 30818145
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.
    Lystad JU; Falkum E; Mohn C; Haaland VØ; Bull H; Evensen S; Rund BR; Ueland T
    Psychiatry Res; 2014 Dec; 220(3):1094-101. PubMed ID: 25242432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cognitive Assessment Interview: A comparative study in first episode and chronic patients with psychosis.
    Sánchez-Torres AM; Elosúa MR; Lorente-Omeñaca R; Moreno-Izco L; Peralta V; Cuesta MJ
    Schizophr Res; 2016 Dec; 178(1-3):80-85. PubMed ID: 27617413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Working memory predicts presence of auditory verbal hallucinations in schizophrenia and bipolar disorder with psychosis.
    Jenkins LM; Bodapati AS; Sharma RP; Rosen C
    J Clin Exp Neuropsychol; 2018 Feb; 40(1):84-94. PubMed ID: 28562181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis.
    Bowie CR; Best MW; Depp C; Mausbach BT; Patterson TL; Pulver AE; Harvey PD
    Bipolar Disord; 2018 Nov; 20(7):604-613. PubMed ID: 29777563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis.
    Cuesta MJ; Peralta V; Zarzuela A
    Schizophr Res; 2007 Sep; 95(1-3):39-47. PubMed ID: 17651943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calibration and cross-validation of MCCB and CogState in schizophrenia.
    Lees J; Applegate E; Emsley R; Lewis S; Michalopoulou P; Collier T; Lopez-Lopez C; Kapur S; Pandina GJ; Drake RJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3873-82. PubMed ID: 26018529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
    Carpenter WT; Bustillo JR; Thaker GK; van Os J; Krueger RF; Green MJ
    Psychol Med; 2009 Dec; 39(12):2025-42. PubMed ID: 19796428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the MoCA for cognitive impairment screening in long-term psychosis patients.
    Gil-Berrozpe GJ; Sánchez-Torres AM; García de Jalón E; Moreno-Izco L; Fañanás L; Peralta V; Cuesta MJ;
    Schizophr Res; 2020 Feb; 216():429-434. PubMed ID: 31801676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures.
    Vares M; Ekholm A; Sedvall GC; Hall H; Jönsson EG
    Psychopathology; 2006; 39(6):286-95. PubMed ID: 16960467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairments in patients with first episode psychosis: The relationship between neurophysiological and neuropsychological assessments.
    Morales-Muñoz I; Jurado-Barba R; Fernández-Guinea S; Álvarez-Alonso MJ; Rodríguez-Jiménez R; Jiménez-Arriero MA; Rubio G
    J Clin Neurosci; 2017 Feb; 36():80-87. PubMed ID: 27825609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale.
    Lenderking WR; Atkinson MJ; Ladd MK; Savva Y; Sommer S; Sidovar M; Hastedt C
    J Patient Rep Outcomes; 2024 Jun; 8(1):61. PubMed ID: 38884842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.
    Fitzgerald D; Lucas S; Redoblado MA; Winter V; Brennan J; Anderson J; Harris A
    Aust N Z J Psychiatry; 2004 Jul; 38(7):501-10. PubMed ID: 15255822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and validation of a brief scale for cognitive evaluation in people with a diagnosis of schizophrenia (BCog-S).
    Sánchez-Martínez V; Sales-Orts R
    J Psychiatr Ment Health Nurs; 2020 Oct; 27(5):543-552. PubMed ID: 31976597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.